The U.S. Food and Drug Administration (FDA) has granted approval to Axsome Therapeutics’ Auvelity (dextromethorphan HBr and bupropion HCl) for…
Read More
Real-Time Observation of Metal-Induced Protein Clumping Offers New Pathways for Alzheimer’s Treatment Strategies
In a significant advancement for neurodegenerative research, a team of scientists at Oregon State University, in collaboration with a dedicated…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delays in Alzheimer’s Onset and Cognitive Decline
Engaging in a consistent regimen of mentally stimulating activities throughout the course of one’s life—ranging from childhood literacy to adult…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A landmark longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Loss of Smell in Early Alzheimer’s Linked to Immune System Attacks on Olfactory Nerve Fibers
For decades, the clinical hallmark of Alzheimer’s disease has been the progressive erosion of memory and cognitive function. However, emerging…
Read More
Johns Hopkins Researchers Identify Critical Protein Pathway in Alzheimer’s Disease Linked to Hydrogen Sulfide Production
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the understanding of Alzheimer’s disease, identifying a specific protein…
Read More
Oregon State University Researchers Unveil Real-Time Breakthrough in Alzheimer’s Protein Clumping Dynamics
The pursuit of a definitive treatment for Alzheimer’s disease has long been hindered by the microscopic complexity of the human…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Onset and Slower Mental Decline
A comprehensive study published in the medical journal of the American Academy of Neurology, Neurology, has revealed a profound correlation…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Immune System Response in the Brain Identified as Primary Cause for Early Olfactory Loss in Alzheimer’s Disease
A groundbreaking study conducted by researchers at the German Center for Neurodegenerative Diseases (DZNE) and Ludwig-Maximilians-Universität München (LMU) has revealed…
Read More
